Ziopharm Oncology
- Business
Ziopharm Oncology Names Sath Shukla as Chief Financial Officer
BOSTON — Ziopharm Oncology, Inc., a clinical stage immuno-oncology company developing next-generation cell and gene therapies, has appointed Satyavrat “Sath”…
Read More »